NCT06534658Recruiting
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
Source: ClinicalTrials.gov · Last updated 2 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This project is a multicenter observational study that establishes a longitudinal cohort of patients with Alzheimer's disease and other dementias based on neuroimaging, molecular imaging, biological and digital markers to explore new solutions such as dementia disease mechanism, diagnosis, condition evaluation, and prognosis assessment.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 18 Jul 2024
- Start date
- 30 Jul 2020
- Primary completion date
- 30 Jul 2029
- Lead sponsor
- Ruijin Hospital
- Diseases
- Alzheimer disease
- NCT number
- NCT06534658
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 30 Jul 2020 to the primary completion date, 30 Jul 2029
- 8 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- The presence of other neurological diseases that may cause brain dysfunction (such as depression, brain tumors, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, normal intracranial pressure hydrocephalus, etc.);
- The presence of other systemic diseases that may cause cognitive impairment (such as liver dysfunction, renal dysfunction, thyroid dysfunction, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.);
- Suffering from a disease that makes it impossible to cooperate with cognitive examinations;
Other
- The presence of contraindications to MRI;
- The presence of mental and neurological retardation;
- Refusing to draw blood;
- Refusing to sign the informed consent form.
Who the study is looking for
- Patients aged ≥50 and ≤85 years old, male or female;
- Meet the diagnostic criteria for dementia or MCI;
- Neuropsychological score: MMSE 15-28 points, CDR ≤ 1 point; ④ Patients and their families are informed and sign the informed consent form
Age in the registry: 50 years to 85 years · Sex: All
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chinese People's Liberation Army General Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
| Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine Coordinator of this site? Confirm its status | Cangzhou | China | Recruiting |
| First Affiliated Hospital of Zhejiang University School of Medicine Coordinator of this site? Confirm its status | Hanzhong | China | Recruiting |
| Qilu Hospital of Shandong University, Qingdao Branch Coordinator of this site? Confirm its status | Qingdao | China | Recruiting |
| Xinhua Hospital Affiliated To Shanghai Jiao tong University School of Medicine Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
| Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
| The First Affiliated Hospital of China Medical University Coordinator of this site? Confirm its status | Shenyang | China | Recruiting |
| The Second Hospital of Hebei Medical University Coordinator of this site? Confirm its status | Shijiazhuang | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.